⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EXEL News
Exelixis Inc
Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market USA - English APAC - Traditional Chinese USA - English
prnewswire.com
AAPL
TSLA
XOM
MSFT
GOOGL
AMZN
NVDA
META
BRK.A
JPM
V
JNJ
PG
MA
HD
UNH
DIS
BAC
PFE
MRK
TMO
ABT
MDT
BMY
AMGN
GILD
AZN
LLY
BIIB
REGN
VRTX
ALGN
ISRG
TDOC
EXAS
ZLAB
SCHR
APT
BILI
HSAI
UBOT
TIGR
INSM
YXT
CCEL
IMUX
INCY
CRSP
EDIT
NTLA
SRPT
EXEL
LULU
CROX
NKE
CPRI
PVH
RL
URBN
M
KSS
TJX
BBY
ROST
DLTR
WMT
TGT
COST
SBUX
MCD
CMG
YUM
QSR
CBRL
TXRH
NDSN
TTWO
EA
NTDOY
SONY
MSGS
AMC
IMAX
RCL
CCL
NCLH
AAL
DAL
UAL
LUV
ALK
JBLU
SKX
ADBE
CRM
INTC
AMD
QCOM
AMAT
MU
NXPI
SNPS
CDNS
ASML
PAYX
ADP
NOW
CSCO
ORCL
IBM
HPQ
DELL
ACN
INFY
SAP
ERIC
NOK
STM
UL
PEP
KO
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer
businesswire.com
EXEL
EXEL Industries: Q1 2025–2026 revenue -17.5%
globenewswire.com
EXEL
Exelixis to Release Fourth Quarter and Fiscal Year 2025 Financial Results on Tuesday, February 10, 2026
businesswire.com
EXEL
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
prnewswire.com
EXEL
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL
Glioblastoma Multiforme Treatment Market to Worth Over US$ 6.1 Billion by 2033 | Astute Analytica
globenewswire.com
MRNA
BMY
EXEL
NOV
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026
businesswire.com
EXEL
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026
businesswire.com
EXEL
Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange USA - English APAC - Traditional Chinese APAC - English USA - English
prnewswire.com
EXEL
SCHR